176 related articles for article (PubMed ID: 34100292)
1. Novel associations between
Packiasabapathy S; Aruldhas BW; Zhang P; Overholser BR; Quinney SK; Sadhasivam S
Pharmacogenomics; 2021 Jul; 22(10):591-602. PubMed ID: 34100292
[No Abstract] [Full Text] [Related]
2. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
[TBL] [Abstract][Full Text] [Related]
3. Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and Metabolism.
Kharasch ED; Regina KJ; Blood J; Friedel C
Anesthesiology; 2015 Nov; 123(5):1142-53. PubMed ID: 26389554
[TBL] [Abstract][Full Text] [Related]
4. A Novel Perioperative Multidose Methadone-Based Multimodal Analgesic Strategy in Children Achieved Safe and Low Analgesic Blood Methadone Levels Enabling Opioid-Sparing Sustained Analgesia With Minimal Adverse Effects.
Sadhasivam S; Aruldhas BW; Packiasabapathy S; Overholser BR; Zhang P; Zang Y; Renschler JS; Fitzgerald RE; Quinney SK
Anesth Analg; 2021 Aug; 133(2):327-337. PubMed ID: 33481403
[TBL] [Abstract][Full Text] [Related]
5. Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics.
Ahmad T; Valentovic MA; Rankin GO
Biochem Pharmacol; 2018 Jul; 153():196-204. PubMed ID: 29458047
[TBL] [Abstract][Full Text] [Related]
6. Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.
Chawar C; Hillmer A; Lamri A; Kapczinski F; Thabane L; Pare G; Samaan Z
PLoS One; 2021; 16(12):e0261201. PubMed ID: 34910759
[TBL] [Abstract][Full Text] [Related]
7. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT).
Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
Drug Alcohol Depend; 2016 Aug; 165():143-50. PubMed ID: 27289271
[TBL] [Abstract][Full Text] [Related]
8. Methadone pharmacogenetics in vitro and in vivo: Metabolism by CYP2B6 polymorphic variants and genetic variability in paediatric disposition.
Wang PF; Sharma A; Montana M; Neiner A; Juriga L; Reddy KN; Tallchief D; Blood J; Kharasch ED
Br J Clin Pharmacol; 2022 Nov; 88(11):4881-4893. PubMed ID: 35538637
[TBL] [Abstract][Full Text] [Related]
9. Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities.
Ahmad T; Sabet S; Primerano DA; Richards-Waugh LL; Rankin GO
J Anal Toxicol; 2017 May; 41(4):325-333. PubMed ID: 28184434
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients.
Yang HC; Chu SK; Huang CL; Kuo HW; Wang SC; Liu SW; Ho IK; Liu YL
PLoS Genet; 2016 Mar; 12(3):e1005910. PubMed ID: 27010727
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
Gerber JG; Rhodes RJ; Gal J
Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
[TBL] [Abstract][Full Text] [Related]
12. CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer.
Wang SC; Ho IK; Tsou HH; Tian JN; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Lin KM; Chen CY; Liu SC; Wu HY; Chan HW; Tsai MH; Lin PS; Liu YL
J Clin Psychopharmacol; 2011 Aug; 31(4):463-9. PubMed ID: 21694616
[TBL] [Abstract][Full Text] [Related]
13. OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children.
Balyan R; Zhang X; Chidambaran V; Martin LJ; Mizuno T; Fukuda T; Vinks AA; Sadhasivam S
Pharmacogenomics; 2017 May; 18(7):621-629. PubMed ID: 28470102
[TBL] [Abstract][Full Text] [Related]
14. Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment.
Kringen MK; Chalabianloo F; Bernard JP; Bramness JG; Molden E; Høiseth G
Ther Drug Monit; 2017 Oct; 39(5):550-555. PubMed ID: 28723731
[TBL] [Abstract][Full Text] [Related]
15. CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study.
AlMeman AA; Ismail R; Perola M
Drug Metab Lett; 2016; 10(3):213-218. PubMed ID: 27515451
[TBL] [Abstract][Full Text] [Related]
16. Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.
Dobrinas M; Crettol S; Oneda B; Lahyani R; Rotger M; Choong E; Lubomirov R; Csajka C; Eap CB
Pharmacogenet Genomics; 2013 Feb; 23(2):84-93. PubMed ID: 23249875
[TBL] [Abstract][Full Text] [Related]
17. Differences in Methadone Metabolism by CYP2B6 Variants.
Gadel S; Friedel C; Kharasch ED
Drug Metab Dispos; 2015 Jul; 43(7):994-1001. PubMed ID: 25897175
[TBL] [Abstract][Full Text] [Related]
18. Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.
Victorri-Vigneau C; Verstuyft C; Bouquié R; Laforgue EJ; Hardouin JB; Leboucher J; Le Geay B; Dano C; Challet-Bouju G; Grall-Bronnec M
Br J Clin Pharmacol; 2019 Jul; 85(7):1538-1543. PubMed ID: 30907440
[TBL] [Abstract][Full Text] [Related]
19. Distribution of alleles, genotypes and haplotypes of the CYP2B6 (rs3745274; rs2279343) and CYP3A4 (rs2740574) genes in the Malian population: Implication for pharmacogenetics.
Kassogue Y; Diakite B; Kassogue O; Konate I; Tamboura K; Diarra Z; Maiga M; Dehbi H; Nadifi S; Traore CB; Kamate B; Dao S; Doumbia S; Dolo G
Medicine (Baltimore); 2021 Jul; 100(29):e26614. PubMed ID: 34398016
[TBL] [Abstract][Full Text] [Related]
20. Assessment of CYP450 genetic variability effect on methadone dose and tolerance.
Tsai HJ; Wang SC; Liu SW; Ho IK; Chang YS; Tsai YT; Lin KM; Liu YL
Pharmacogenomics; 2014 May; 15(7):977-86. PubMed ID: 24956251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]